Data were derived from de-identified electronic health record (EHR) extracts including medication orders, patient demographics, and longitudinal weight measurements
6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease
SURMOUNT-1 Investigators
This non-standard amino acid has a bulkier side chain than alanine, and DPP-4 simply cannot get a grip on it
However, if you experience severe reactions, you should stop using the medication and consult your healthcare provider immediately
Researchers have yet to examine strategies to preserve or increase muscle mass during weight loss induced by GLP-1 drugs